(Q35187778)

7 August 2017

1 reference

title

Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention (English)

1 reference

attention deficit hyperactivity disorder

7 August 2017

1 reference

0 references

author name string

J K Buitelaar

1

1 reference

7 August 2017

S A Montgomery

2

1 reference

7 August 2017

B J van Zwieten-Boot

3

1 reference

7 August 2017

European College of Neuropsychopharmacology Consensus Committee

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

European Neuropsychopharmacology

7 August 2017

published in

1 reference

7 August 2017

volume

13

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

297-304

1 reference

Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS).

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

The Child and Adolescent Psychiatric Assessment (CAPA).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Psychiatric sequelae of low birth weight at 6 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Early externalizing behavior problems: toddlers and preschoolers at risk for later maladjustment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Quantitative Brain Magnetic Resonance Imaging in Attention-Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Parent and Teacher Ratings of ADHD Symptoms: Psychometric Properties in a Community-Based Sample

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

ADHD boys in young adulthood: psychosocial adjustment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

The comorbidity of ADHD in the general population of Swedish school-age children.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Adult psychiatric status of hyperactive boys grown up.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Associations between event-related potentials and measures of attention and inhibition in the Continuous Performance Task in children with ADHD and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Diagnostic status and symptomatic behavior of hard-to-manage preschool children in middle childhood and early adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Tricyclic antidepressants in the treatment of children with attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Diagnostic interview for children and adolescents (DICA)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

A children's global assessment scale (CGAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Globalisation of international health

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Hyperactivity and conduct problems as risk factors for adolescent development

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Genetic basis of attention deficit and hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900047-6

7 January 2021

10.1016/S0924-977X(03)00047-6

Identifiers

DOI

1 reference

7 August 2017

1 reference